- (2R,2’R,3R,3’R)-4,4′-di(anthracen-9-yl)-3,3′-di-tert-butyl-2,2’,3,3′-tetrahydro-2,2′-bibenzo[d][1,3]oxaphosphole,99% purity,>99%ee, 25mg
- (2R,2’R,3R,3’R)-4,4′-di(anthracen-9-yl)-3,3′-di-tert-butyl-2,2’,3,3′-tetrahydro-2,2′-bibenzo[d][1,3]oxaphosphole,99% purity,>99%ee, 250mg
- (2R,2’R,3R,3’R)-4,4′-di(anthracen-9-yl)-3,3′-di-tert-butyl-2,2’,3,3′-tetrahydro-2,2′-bibenzo[d][1,3]oxaphosphole,99% purity,>99%ee, 500mg
- (2R,2’R,3R,3’R)-4,4′-di(anthracen-9-yl)-3,3′-di-tert-butyl-2,2’,3,3′-tetrahydro-2,2′-bibenzo[d][1,3]oxaphosphole,99% purity,>99%ee, 1g
- (2R,2’R,3R,3’R)-4,4′-di(anthracen-9-yl)-3,3′-di-tert-butyl-2,2’,3,3′-tetrahydro-2,2′-bibenzo[d][1,3]oxaphosphole,99% purity,>99%ee, 100mg
- 1,1′-[(5aR,8aR,14aR)-5a,6,7,8,8a,9-Hexahydro-5H-[1]Benzopyrano[3,2-d]Xanthene-1,13-Diyl]Bis[1,1-di(3,5-Dimethylphenylphosphine,98%purity,99%ee, 50mg
- 1,1,1-Trifluoro-N-[(11aR)-10,11,12,13-tetrahydro-5-oxido-3,7-bis(2,4,6-trisisopropylphenyl)diindeno[7,1-de:1’,7′-fg][1,3,2]dioxaphosphocin-5-yl]methanesulfonamide,≥98%, ≥99%ee, 50mg